SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001104659-23-053003
Filing Date
2023-04-28
Accepted
2023-04-28 16:20:12
Documents
3

Document Format Files

Seq Description Document Type Size
1 DEF 14A tm231964d3_def14a.htm DEFA14A 15181
2 GRAPHIC tm231964d3_def14aimg001.jpg GRAPHIC 489131
3 GRAPHIC tm231964d3_def14aimg002.jpg GRAPHIC 503728
  Complete submission text file 0001104659-23-053003.txt   1383840
Mailing Address 1111 BOUL. DR.-FREDERIK-PHILIPS, STE 420 MONTREAL A8 H4M 2X6
Business Address 1111 BOUL. DR.-FREDERIK-PHILIPS, STE 420 MONTREAL A8 H4M 2X6 (514) 336-0444
Milestone Pharmaceuticals Inc. (Filer) CIK: 0001408443 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A8 | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-38899 | Film No.: 23866618
SIC: 2834 Pharmaceutical Preparations